Therapeutic Effects of Photobiomodulation Therapy on Multiple Sclerosis by Regulating the Inflammatory Process and Controlling Immune Cell Activity: A Novel Promising Treatment Target

被引:7
|
作者
Vafaei-Nezhad, Saeed [1 ,2 ]
Niknazar, Somayeh [3 ,4 ]
Payvandi, Ali Asghar [4 ]
Tehrani, Atefeh Shirazi [5 ]
Roozbahany, Navid Ahmady [4 ]
Ahrabi, Behnaz [2 ,5 ]
Abbaszadeh, Hojjat Allah [2 ,4 ,7 ]
Darabi, Shahram [6 ]
机构
[1] Birjand Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Dept Anat Sci, Birjand, Iran
[2] Shahid Beheshti Univ Med Sci, Laser Applicat Med Sci Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohada Tajrish Comprehens Neurosurg Ctr Excellenc, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Hearing Disorders Res Ctr, Tehran, Iran
[5] Shahid Beheshti Univ Med, Sch Med, Dept Biol & Anat Sci, Tehran, Iran
[6] Qazvin Univ Med Sci, Res Inst Noncommunicable Dis, Cellular & Mol Res Ctr, Qazvin, Iran
[7] Loghman Hakim Hosp, Hearing Disorders Res Ctr, Tehran, Iran
关键词
Multiple sclerosis; Photobiomodulation; Myelin; Central nervous system; LEVEL LASER THERAPY; SPINAL-CORD-INJURY; OXIDATIVE STRESS; DISEASE; IRRADIATION; DYSFUNCTION; EXPRESSION; RECOVERY; LIGHT; MODEL;
D O I
10.34172/jlms.2022.32
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Multiple sclerosis (MS) is one of the autoimmune and chronic diseases of the central nervous system; this disease occurs more frequently in young people and women and leads to neurological symptoms. Oxidative stress, inflammatory processes, and oligodendrocyte dysfunction have a pivotal role in the pathophysiology of this disease. Nowadays it is reported that photobiomodulation (PBM) as a non-invasive treatment has neuroprotective potential, but the exact mechanisms are not understood.Methods: In this study, we reviewed the effects of PBM on MS. In this regard, we used the keywords "Photobiomodulation", "Laser therapy", and "Low-level laser therapy" on MS to find related studies on this subject in PubMed, Google scholar, Elsevier, Medline, and Scopus databases.Results: PBM has positive effects on MS by regulating the inflammatory process, controlling immune cell activity and mitochondrial functions, as well as inhibiting free radicals production which finally leads to a reduction in neurological defects and an improvement in the functional status of patients.Conclusion: Overall, researchers have suggested the use of laser therapy in neurodegenerative diseases due to its numerous therapeutic effects.
引用
收藏
页数:5
相关论文
共 41 条
  • [1] Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes
    Jiang, Wen-Juan
    Peng, Yun-Chuan
    Yang, Kai-Ming
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (04) : 3275 - 3285
  • [2] Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
    Xing, Nan
    Du, Qinyun
    Guo, Sa
    Xiang, Gelin
    Zhang, Yi
    Meng, Xianli
    Xiang, Li
    Wang, Shaohui
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [3] Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
    Nan Xing
    Qinyun Du
    Sa Guo
    Gelin Xiang
    Yi Zhang
    Xianli Meng
    Li Xiang
    Shaohui Wang
    Cell Death Discovery, 9
  • [4] Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas
    Abidi, Afroz
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (01) : 3 - 12
  • [5] Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
    Kim, Kicheol
    Probstel, Anne-Katrin
    Baumann, Ryan
    Dyckow, Julia
    Landefeld, James
    Kogl, Elva
    Madireddy, Lohith
    Loudermilk, Rita
    Eggers, Erica L.
    Singh, Sneha
    Caillier, Stacy J.
    Hauser, Stephen L.
    Cree, Bruce A. C.
    Team, Ucsf MS-EPIC
    Schirmer, Lucas
    Wilson, Michael R.
    Baranzini, Sergio E.
    BRAIN, 2021, 144 : 450 - 461
  • [6] Cell-type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
    Kim, K.
    Probstel, A. -K.
    Baumann, R.
    Madireddy, L.
    Dyckow, J.
    Loudermilk, R.
    Eggers, E. L.
    Singh, S.
    Caillier, S. J.
    Hauser, S. L.
    Cree, B. A. C.
    Schirmer, L.
    Wilson, M. R.
    Baranzini, S. E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 896 - 896
  • [7] Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
    Kim, Kicheol
    Proebstel, Anne-Katrin
    Baumann, Ryan
    Dyckow, Julia
    Landefeld, James
    Kogl, Elva
    Madireddy, Lohith
    Loudermilk, Rita
    Eggers, Erica L.
    Singh, Sneha
    Caillier, Stacy J.
    Hauser, Stephen L.
    Cree, Bruce A. C.
    Schirmer, Lucas
    Wilson, Michael R.
    Baranzini, Sergio E.
    BRAIN, 2021, 144 (02) : 450 - 461
  • [8] CD21 positive B cell: A novel target for treatment of multiple sclerosis
    Farjam, Mojtaba
    Ebrahimpour, Azin
    Fakhraei, Bahareh
    MEDICAL HYPOTHESES, 2013, 80 (05) : 556 - 557
  • [9] Changes in Immune Parameters Following Commencement of Laquinimod, a Novel Oral Therapy for the Treatment of Multiple Sclerosis
    Lund, Brett T.
    Stasiolek, Mariusz
    Kelland, Eve E.
    Gaupp, Stefanie
    Gilmore, Wendy
    Linker, Ralf
    Gold, Ralf
    Weiner, Leslie P.
    NEUROLOGY, 2011, 76 (09) : A139 - A139
  • [10] Cerebrospinal Fluid Immune Cell Phenotyping And Neurofilament Light Chain Measurements As Biomarkers Of Inflammatory Activity And Disease Modifying Therapy Responsiveness In Multiple Sclerosis
    Arsenault, S. T.
    Fudge, N.
    Blandford, S.
    Clift, F.
    Stefanelli, M.
    Moore, C. S.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 23 - 23